Delivery Order SPE2DB20D7059-SPE2DB24FQMP9
Award Date
9/13/24
Potential Completion Date
9/16/24
Potential Value
$5.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with ID SPE2DB20D7066|SPE2DB25FC2DP, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,203.28 firm-fixed-price delivery order is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The contract has a firm fixed price of $1,432.08 and a period of performance ending on May 28, 2025. The contract is not set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,155.72, is for a Firm Fixed Price Delivery Order to provide JOLESSA 0.15 MG-0.03 MG TABLET 91S, a type of prescription medication. The contract has an ultimate completion date of June 11, 2025 and is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a significant...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FPN02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,062.82, is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The contract is a Delivery Order and has a Firm Fixed Price pricing type. It does not have a set-aside designation, indicating open competition....
This federal contract award, SPE2DB20D1004|SPE2DB22FF1S5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,105.57 delivery order is for the supply of 4556076572 - JOLESSA 0.15 MG-0.03 MG TABLET 91S. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,310.48 firm fixed price delivery order is for the supply of JOLESSA 0.15 MG-0.03 MG tablets. This contract does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that holds several large Indefinite Delivery Contracts (IDCs) with the federal government, including a single-award IDC with DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract has a ceiling value of $1,213.53 and an ultimate completion date of May 21, 2024. It is a firm fixed-price delivery order contract type. The award is not associated with a set-aside program. AmerisourceBergen Drug Corp. is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products...
This federal contract award is for a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a prescription medication, with a ceiling value of $1,178.12 and a period of performance through May 8, 2025. The contract is a firm fixed-price delivery order and is not set aside for any particular business category. Amerisourcebergen...
This is a $1,663.68 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565221558 JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment...
This federal contract award, SPE2DB20D1050|SPE2DB24FH86Q, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract is a firm fixed-price delivery order with a ceiling value of $1,840.93 and an ultimate completion date of August 27, 2024. This contract is not set aside for any specific business type. AmerisourceBergen, through its Corporate Office Division, will be...